Malaria: new tools for zero deaths and elimination

7 March, 2012

Hon Professor C O Onyebuchi Chukwu

New insecticides, against mosquitos, new drugs and a potential vaccine for children could be game-changers in the fight to tackle malaria. Our recent meeting discussed how these potential tools could be integrated into existing control measures.

Malaria: new tools for zero deaths and elimination

Monday 23 – Wednesday 25 April 2012 (WP1141)

Following on from our 2009 Malaria: getting to zero meeting, the focus of this year’s round table discussion was the incorporation of new and potential tools into on-going malaria control programmes. The meeting focused on new drugs in the pipeline, how to increase the range of insecticides to reduce resistance, and the vaccine candidate RTS, which is being trialled and could be available in early 2016.

Maintaining the gains achieved by current technologies and interventions, and expanding these further, is a key priority. However, research is rapidly bringing better drugs, new insecticides and a potential vaccine. The meeting highlighted the need to incorporate these in a judicious way, with local decision-making about the adoption of new technologies being critical. Some of these new technologies (such as single dose curative drugs, better drugs against vivax and new and potent insecticides, and a vaccine) will undoubtedly accelerate progress on lower mortality.

Mrs Chioma Amajoh, Hon Professor C O Onyebuchi Chukwu, Dr Constance Bart-Plange & Dr Emmanuel Meribole

Mrs Chioma Amajoh, Hon Professor C O Onyebuchi Chukwu, Dr Constance Bart-Plange & Dr Emmanuel Meribole

 

This conference was organised in association with:

  • The Global Health Group
  • University of California, San Francisco (UCSF)
  • GlaxoSmithKline
  • Medicines for Malaria Venture
  • Novartis
  • PATH Malaria Vaccine Initiative
  • Vestergaard Frandsen

Further information

Conference on Malaria – integration of new tools for zero deaths and elimination

Stay up to date

Sign up to our newsletter